Main Menu

Calliditas Therapeutics AB

(NASDAQ GS: CALT)

Rigrodsky Law, P.A. is investigating Calliditas Therapeutics AB (“Calliditas”) regarding possible breaches of fiduciary duties and other violations of law related to Calliditas’ agreement to be acquired by Asahi Kasei Corporation. Under the terms of the agreement, Calliditas shareholders will receive SEK 416 in cash per American Depositary share.

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to info@rl-legal.com.

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 06/14/2024


* Indicates a required field.

Back to Page